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Abstract 
Background: Public health advocacy is important in preventing harm and promoting health in 
communities. There has been little research into public health advocacy strategies which address 
gambling related harms. This study aimed to identify the role of advocacy in gambling reform, challenges 
to gambling advocacy implementation, and strategies that could facilitate change. 
Methods: Semi-structured qualitative interviews were conducted with a sample of 50 stakeholders with 
backgrounds in gambling policy, research, health promotion, and advocacy. Participants were asked 
about how advocacy could be used to address gambling harm, and the range of barriers and facilitators 
for effective advocacy responses. A constant comparative method of analysis was used on the data. 
Results: While participants perceived that there was a role for advocacy in preventing and reducing 
gambling related harm, they discussed a range of challenges. These included restrictions associated with 
funding of research and services, the power of the gambling industry, and the role of stigma in preventing 
people with lived experience of gambling from speaking about their experiences. Participants also 
described a range of facilitators of public health advocacy approaches, including independent funding 
sources, reframing the 'responsibility' debate, developing opportunities and capacity for people with lived 
experience of harm, and developing broadly based coalitions to enable cohesive and consistent advocacy 
responses to gambling harm. 
Conclusion: There is a clear role for public health advocacy approaches aimed at preventing and reducing 
gambling harm. Future research could identify how advocacy strategies may be implemented as a part of 
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Abstract  38 
Background: Public health advocacy is important in preventing harm and promoting 39 
health in communities. There has been little research into public health advocacy 40 
strategies that address gambling related harms. This study aimed to identify the role 41 
of advocacy in gambling reform, challenges to gambling advocacy implementation 42 
and strategies that could facilitate change.  43 
 44 
Methods: Semi-structured qualitative interviews were conducted with a sample of 50 45 
stakeholders with backgrounds in gambling policy, research, health promotion and 46 
advocacy. Participants were asked about how advocacy could be used to address 47 
gambling harm, and the range of barriers and facilitators for effective advocacy 48 
responses. A constant comparative method of analysis was used on the data.  49 
 50 
Results: While participants perceived that there was a role for advocacy in 51 
preventing and reducing gambling related harm, they discussed a range of 52 
challenges. These included restrictions associated with funding of research and 53 
services, the power of the gambling industry, and the role of stigma in preventing 54 
people with lived experience of gambling from speaking about their experiences. 55 
Participants also described a range of facilitators of public health advocacy 56 
approaches, including independent funding sources, reframing the ‘responsibility’ 57 
debate, developing opportunities and capacity for people with lived experience of 58 
harm, and developing broadly-based coalitions to enable cohesive and consistent 59 
advocacy responses to gambling harm.  60 
 61 
Conclusion: There is a clear role for public health advocacy approaches aimed at 62 
preventing and reducing gambling harm. Future research could identify how 63 
advocacy strategies may be implemented as part of a comprehensive public health 64 




Keywords: Advocacy, Gambling, Public health  67 





The role of advocacy is a rapidly growing area of interest in gambling reform 71 
(Thomas et al. 2015). Although there have been numerous calls for the reform of the 72 
gambling industry and its products, popular approaches have predominantly used an 73 
addiction-oriented approach, focusing on personal responsibility strategies to 74 
minimise harm (Miller et al. 2014; Hancock and Smith 2017). However, there is a 75 
long tradition in public health of using a variety of advocacy strategies as part of a 76 
comprehensive approach to protect and promote positive health outcomes in 77 
communities (Moore et al. 2013). Successful public health interventions have been 78 
achieved as the result of strong scientific evidence, community support, and 79 
advocacy as the drivers of policy change (Chapman 2004a; Daube 2017). Such 80 
strategies are strongly linked to action, engaging communities, and creating robust 81 
arguments for change (Bassett 2003). Advocacy includes ‘spreading the word’ to the 82 
community and decision-makers about strategies and policies that need to be 83 
enacted to protect and promote the health of communities (Avery and Bashir 2003 84 
p.1207), and persuading: 85 
 86 
 “…decision makers of the need for change through identifying desired public 87 
health outcomes and effective and feasible methods of achieving that change” 88 
(Moore et al. 2013 p.5) 89 
 90 
Although there is no single formula for effective advocacy, a range of individual and 91 
collective strategies may facilitate successful campaigns (Jenkins 2006). Strategies 92 
can be grouped into five key approaches that are not necessarily mutually exclusive. 93 
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First are strategies that seek to influence policy change through the use of sound 94 
scientific evidence to highlight harms, challenge existing policy, and push for policy 95 
reform (Cullerton et al. 2016; Elliott-Green et al. 2016; Cohen and Marshall 2017). 96 
Second, is the development of strong coalitions and partnerships across agencies 97 
(such as health and other professional organisations) united by a common goal, 98 
which enable the fostering and use of explicit skill sets and greater access to a 99 
broader range of policy and decision-makers (Frieden 2014; Cullerton et al. 2016; 100 
Cohen and Marshall 2017). Third, are strategies that seek to raise awareness and 101 
frame the public debate about key issues, particularly through the development of 102 
key messaging strategies and the use of the media (Chapman 2004b Freudenberg 103 
2005; Gen and Wright 2013). Fourth, are strategies that aim to empower 104 
communities, by providing a strong voice for individuals who are marginalised or 105 
unable to speak for themselves (Dorfman and Krasnow 2014), educating 106 
communities about product harms (Freudenberg 2005; Chaloupka et al. 2011; 107 
Brinsden and Lang 2015), and encouraging community participation in reform 108 
initiatives (Cohen and Marshall 2017). Finally, are strategies that monitor and 109 
counter vested influences that seek to resist and create barriers when industry 110 
reform efforts may be implemented (Chapman 2007; Jahiel and Babor 2007; 111 
Thomas et al. 2015). 112 
 113 
Along with documenting facilitators for advocacy, researchers have identified a 114 
number of issues that may create barriers to successful public health advocacy 115 




First, public health advocates can encounter significant opposition to reform 118 
agendas, particularly when advocating for policy change that conflicts with the socio-119 
cultural, political or economic interests of dominant social agencies, governments, or 120 
industries (Andrews and Edwards 2004). Chapman (2004a) has commented that 121 
public health advocates often encounter fraught and highly organised opposition to 122 
change from a range of agencies: 123 
 124 
“Opposition can come from governments, industry, community and religious 125 
interest groups, and from within the public health field itself.” (Chapman 2004b 126 
p.361) 127 
 128 
Second, are the challenges that arise from the commercial interests of large 129 
corporations, and the resourcing and influence that these bring. These include the 130 
ability of large organisations to influence governments through means such as using 131 
political donations, paid lobbyists, and political advertising and campaigning 132 
(Brownell and Warner 2009; Hawkins et al. 2012; Freudenberg 2014). In contrast, 133 
there are few resources for public health advocacy or translation initiatives, which 134 
arguably remain the ‘poor cousin’ within the public health field (Chapman 2001). 135 
Corporate Social Responsibility (CSR) initiatives are another example of strategies 136 
used by industries as a public relations tool, through the support of community 137 
programs, donations to charities, and the provision of resources for youth initiatives 138 
(Rosenberg and Siegel 2001; Lyness and McCambridge 2014; Richards et al. 2015). 139 
When industries create positive perceptions in the community, and a reliance on 140 
industry funding, it may be difficult for community organisations to move away from 141 
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relationships with these companies, to advocate for the promotion of health (Jane 142 
and Gibson 2017).  143 
 144 
Third, are the challenges resulting from funder influence over research (Chapman 145 
2001; Livingstone and Adams 2016). For example, a recent study of funder influence 146 
over published research outputs in a major addiction journal identified that around 147 
one third of authors (n=117, 36%) had experienced at least one incident of funder 148 
interference in their research including the censorship of research findings, the 149 
language used in reports, the writing of reports, and when and how findings were 150 
released (Miller et al. 2017). Researchers have also explored government 151 
suppression of health information in the Australian health sector, identifying that 152 
governments delayed or prohibited publications, using a range of methods of 153 
suppression that included blocking funding, delaying access to data, controlling 154 
report findings, and sanitising reports (Yazahmeidi and Holman 2007). Such 155 
suppression may impact on a researcher’s ability to use scientific evidence to argue 156 
for policy reform, or regulatory change. 157 
 158 
Finally, there are the debates about whether and to what extent academics should 159 
be involved in advocacy. Smith and Stewart (2017) identified a number of challenges 160 
for academics engaging in advocacy, including the perceived ethical implications of 161 
traditional researchers moving beyond their research findings to provide policy 162 
recommendations; a perception that involvement in advocacy initiatives was for 163 
ideological rather than empirically driven reasons; and concerns that continued 164 
involvement in advocacy might compromise perceptions of research independence 165 
and credibility (Smith and Stewart 2017). Further to this is the concern that 166 
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academics are often judged by conventional research outputs, but rarely by their 167 
broader impact (Mirvis 2009; Vale and Karataglidis 2016). This may ultimately limit 168 
the involvement of academics in policy development (Lauder 2014). 169 
 170 
How then do those who wish to engage in advocacy in the area of gambling 171 
negotiate their way through the range of challenges and facilitators to effective 172 
advocacy initiatives? In particular, how does this occur when there is significant 173 
opposition from vested interests? Although the shift to a public health approach to 174 
gambling reform is gaining momentum, researchers have documented significant 175 
barriers to this, including challenges in producing scientific research (Adams 2011; 176 
Cassidy et al. 2013). Utilising qualitative interviews with an international sample of 177 
health promotion workers, researchers, policy makers, and advocates working in 178 
gambling harm reduction and prevention, we posed three research questions:  179 
 180 
1. What are the challenges and facilitators to effective advocacy initiatives? 181 
2. Which strategies are most effective in countering opposition, and building 182 
feasible methods for change?  183 
3. What role can advocacy play in reducing and preventing gambling related 184 
harm? 185 
 186 
Methods  187 
 188 




The data presented in this paper was collected within a broader study of the range of 191 
issues contributing to the normalisation of gambling (Thomas et al. in press). The 192 
present study specifically explored questions regarding the role of advocacy in 193 
gambling harm prevention and reform. Constructivist Grounded Theory (CGT) 194 
methods were used in the creation of research questions, data collection and 195 
analysis (Charmaz 2006). CGT recognises the subjective nature of data collection 196 
and analysis, the interactions between study participants and researchers, and how 197 
the researcher is situated within the interpretation of study data (Charmaz and 198 
Belgrave 2012). The use of CGT methods resulted in an interpretive data analysis 199 
and descriptive presentation of study findings (Charmaz and Belgrave 2012).  200 
  201 
Sample selection and recruitment 202 
 203 
To guide the sample selection for this study, we used the stakeholder categories 204 
outlined in the Australian National Preventive Health Agency Stakeholder 205 
Engagement Strategy, which included those working in health promotion, academia 206 
or research, government and policy, and in non-governmental organisations, 207 
including peak bodies and advocacy organisations (Australian National Public Health 208 
Agency 2012). To recruit participants, the research team constructed a list of 209 
potential participants in each of the categories, based on their existing networks in, 210 
and, knowledge of the field. The team also scanned websites for additional 211 
researchers and health promotion and non-government organisations involved in 212 
gambling harm prevention activities. Participants were initially approached by email, 213 
with snowball-sampling techniques (Sadler et al. 2010) employed to identify 214 
additional participants, particularly from countries outside Australia. Ethical approval 215 
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was received from the University Human Research Ethics Committee (HEAG-H 216 
01_2016).  217 
 218 
Data collection 219 
 220 
The questions relating to advocacy within the interview schedule focused on three 221 
key themes of inquiry: the role of advocacy in gambling reform; perceived challenges 222 
or facilitators for advocacy; and previously successful advocacy efforts in gambling 223 
harm reduction. Five researchers, including the first and second authors conducted 224 
semi-structured interviews lasting on average 60 minutes. These interviews were 225 
conducted via telephone or Skype and audio-recorded with the permission of 226 
participants. Consistent with qualitative methods (Miles and Huberman 1994) as the 227 
data were collected and analysed, the interview schedule was modified to reflect 228 
new and emerging issues raised by participants.  229 
 230 
Data analysis  231 
 232 
After transcription of the interviews, all data were de-identified to ensure anonymity 233 
of participants, QSR NVivo 10 was used to manage the data. Using a thematic 234 
analysis approach (Miles and Huberman 1994) the first author led the data analysis 235 
process. Each transcript was read, re-read and coded to establish the themes and 236 
sub-themes emerging from the data relevant to the research questions. Using a 237 
process of open coding, emerging themes and sub themes were compared across 238 
the data to enable the identification of any patterns in participant responses. Authors 239 
read the transcripts and engaged in multiple detailed discussions about the 240 
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interpretation of emerging themes and sub-themes, and, the similarities and 241 
differences in responses. The authors regularly returned to study the research 242 
questions and advocacy theory to interpret responses. In instances where the  243 
authors differed in their interpretation, transcripts were again reviewed and analysed, 244 
with discussions between the authors occurring until consensus was reached and 245 
the final themes and subthemes were agreed. While qualitative research does not 246 
seek to provide numerical values to data, in reporting the results of the data we 247 
indicate ‘a few’ to represent less than 25% of participants, ‘some’ as up to 50%, 248 
‘many’ as up to 75%, and ‘most’ as over 75% agreement. 249 
 250 
Results  251 
 252 
A total of 50 participants were interviewed. Although participants were from eight 253 
countries, over half were from Australia (n=32). Participants came from a range of 254 
professional backgrounds, which were grouped into four categories: 1) academics 255 
and researchers (n=19), 2) health promotion organisations (n=16), 3) advocacy, not 256 
for profit, and peak bodies (n=10), and 4) government organisations and policy 257 










Table One 266 
Overview of background of study participants 267 
 268 
      Field 
 
 
















Australia  9 13 6 4 32 
New 
Zealand 




2 0 3 0 5 
Canada 2 0 0 0 2 
United 
Kingdom 
2 0 0 0 2 
Sweden 1 0 0 0 1 
Finland 1 0 0 0 1 
Ireland 0 1 0 0 1 
Total 19 16 10 5 50 
 269 
Participants described a range of challenges to the implementation of effective 270 
advocacy initiatives, and strategies to overcome these challenges.  271 
 272 
Responding to the influence of the gambling industry 273 
 274 
The first theme related to the influence and power of the gambling industry and the 275 
difficulties this created for advocating for comprehensive reduction and prevention 276 
strategies. While a range of industry influences were described, the potential 277 
influences over political decision making, research, and the framing of the public 278 
debate about gambling provided the three biggest challenges for advocates. Some 279 
participants described the powerful mechanisms used by industry to influence 280 
government policy. These included making political donations, lobbying politicians, 281 
and having a seat at the policy making table. Some participants perceived that these 282 
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mechanisms led to the development of government policy and legislation that were 283 
‘sympathetic’ to the industry, and that undermined the ability of public health 284 
advocates to convince governments to implement evidence-based reforms to reduce 285 
gambling harm. One participant described how the power of political donations and 286 
lobbying limited the ability of advocates to influence political decision-makers, and 287 
argue for evidence-based reform:  288 
 289 
“...trying to convince government when there’s significant money that flows to 290 
political parties and politicians from the industry makes it much tougher for 291 
people campaigning and seeking reasonable reforms.” - Participant 20, Policy 292 
 293 
Participants also described the role of industry in influencing research funding 294 
agendas, and in directly (or indirectly) funding academic research. This included 295 
having input into the setting of priorities for research funding agendas. Participants 296 
particularly described the role of industry in raising money for research, sponsoring 297 
academic conferences, and indirectly funding treatment services. One participant 298 
stated that while the gambling industry did not necessarily seek to control or co-opt 299 
research, it ensured that research supported its agenda:  300 
   301 
 “So, it’s not the co-opting of research. It’s rather disproportionately funding 302 
research people and research areas that support their story.” – Participant 4, 303 
Academics/Researchers 304 
 305 
This provided a challenge for public health researchers and advocates who reported 306 
that the involvement of industry in research, or research agenda setting, meant that 307 
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there was limited critique of industry practices and how to counter these. Some 308 
participants also noted that direct or indirect funding of research and treatment 309 
services by industry made it very difficult for researchers and services to speak out 310 
about the harms perpetuated by the gambling industry and its products. Describing 311 
the role of treatment providers, one participant commented:  312 
 313 
“So, they’re very torn; yes, they want to be rid of them (pokies), no, they don't 314 
want to lose funding, and so they end up not doing anything.” – Participant 8, 315 
Health Promotion 316 
 317 
Some described the important role of independent funding sources in enabling 318 
researchers and services providers to persuade decision makers of the need for 319 
regulatory reform of the industry and its products. Participants acknowledged that 320 
independent funding for academic research, treatment services, and community 321 
groups was important in ensuring that messages about reform were not 322 
misrepresented: 323 
 324 
“I think the other thing is independence, so the ability to actually frame issues 325 
and raise issues from the local level without those issues being watered 326 
down, or filtered down, or disrupted.” - Participant 36, 327 
Academics/Researchers 328 
 329 




Participants discussed how the financial capacity of the gambling industry enabled it 332 
to run effective campaigns to frame the debate about problem gambling and to 333 
challenge reform initiatives. Some commented that the industry had been very 334 
effective in framing problem gambling as an issue relating to personal responsibility. 335 
Some participants described the ‘very smart PR and marketing departments’ that 336 
were engaged by the gambling industry, and their ability to mount ‘sophisticated 337 
campaigning’ strategies. One participant noted that the lack of resources available to 338 
advocates was a significant limitation in advocacy initiatives: 339 
 340 
“If the gambling industry can advertise, and the government can advertise, 341 
and the advocacy groups don’t have any money to do anything like that,  342 
that’s a severe limitation… it all comes down to resources.” – Participant 41, 343 
Health Promotion 344 
 345 
Many participants noted the importance of reframing discourse about problem 346 
gambling away from individual responsibility and towards the health and social costs 347 
of gambling harm. This included reframing gambling related harm as a public health 348 
issue, rather than a political or economic issue: 349 
 350 
“They need to continue to talk about the harms. They need to continue to talk 351 
to the government about their role in this as a health issue, a public-health 352 
issue, and try to get the government to stop only looking at it from an 353 
economic point of view….and, oh, to stop framing the problem gambling as an 354 




Some believed that the most effective way of overcoming these resource limitations 357 
was effective engagement with the media. Participants noted that media-based 358 
advocacy enabled a broad reach of messages to key target audiences. These had 359 
impact because governments and the gambling industry were often responsive to 360 
what was ‘said in the media’:  361 
 362 
“It’s only when the public gets really upset with the way in which gambling’s 363 
being delivered and it threatens a politician’s likelihood of being re-elected 364 
things are going to change…So media is very, very important.” – Participant 365 
4, Academics/Researchers 366 
 367 
Participants also noted that there was a critical need for independent (i.e. not aligned 368 
with the gambling industry or government) peak bodies on gambling harm, which 369 
would serve as ‘umbrella organisations’ which could help to reframe the public 370 
debate about gambling, and to drive reform. For example, one participant identified 371 
the Alliance for Gambling Reform (an Australian based coalition of local councils, 372 
churches, and other community organisations concerned about the harms 373 
associated with gambling) as a key driver in reframing the debate about gambling 374 
related harm towards problematic gambling products. Others commented that in the 375 
absence of these peak bodies, researchers, local government, and community 376 
organisations should build and consolidate their networks to work together for 377 
change in local communities. In particular, participants described the need for open, 378 




“We need a national response and strategy to gambling in Australia that is 381 
evidence-informed and treats it as a health and social issue in terms of public 382 
health. Whenever we have a discussion about gambling, we need to include 383 
research, academia, treatment and people who consume gambling products 384 
to ensure that we have an open consultative process about this harmful 385 
product.” - Participant 43, Health Promotion 386 
 387 
Overcoming ideological differences relating to the role of advocacy 388 
 389 
The third theme related to ideological differences between individuals and groups 390 
about advocacy strategies, and the goals and aims of advocacy. While there was 391 
general agreement that advocacy was needed from participants from a range of 392 
professional backgrounds, participants particularly commented on the ideological 393 
differences relating to the involvement of academics in advocacy. A few participants 394 
questioned whether academics should have, or felt comfortable with, a role in 395 
advocacy. One participant commented that academics did not ‘like to consider’ 396 
themselves advocates, that research needed to be purely empirically driven, and that 397 
agendas ran the risk of being motivated ‘purely by ideology’ and ‘not evidence’. 398 
Others were concerned about the impact of the involvement in advocacy on the 399 
reputations of academics, with a few commenting that when researchers became 400 
involved in advocacy their work was often ‘tarnished as unscientific’, or that their 401 
objective could be described as ‘propaganda’.  402 
 403 
Despite this, many participants both within and outside academia believed that 404 
academics had an important role in advocacy initiatives that aimed to influence 405 
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policy and decision makers. Participants noted, that it was important for independent 406 
evidence generated by academics to be effectively disseminated to local groups to 407 
be used in their advocacy campaigns, and that it was important for this evidence to 408 
be shared in ‘an easily digestible format that is reliable and valid and easily 409 
accessible…’.  410 
 411 
Building coalitions and working towards a common goal 412 
 413 
The fourth challenge for advocacy initiatives related to getting diverse groups of 414 
individuals to work together toward a common goal of addressing gambling harm. 415 
Some participants stated that one of the challenges associated with advocacy 416 
initiatives was that while many individuals had advocated for gambling reform, 417 
gambling reform would not be achieved when individuals worked alone or in small 418 
groups. One participant stated that a key difficulty with current advocacy initiatives 419 
was getting individuals to come together and advocate for reform without getting 420 
people ‘offside’:  421 
 422 
“If you have lots of individuals coming together they all have their own story, 423 
their own idea. How do you then drive that to one common goal, and how do 424 
you then get access to the people that you need to get access to in a way that 425 
you’re not going to get them offside?” - Participant 45, Health Promotion 426 
 427 
Participants commented that in order for meaningful reform to occur, academics, 428 
local councils, community groups, and sporting organisations needed to work 429 
together to convince decision makers to enact change. One participant noted that 430 
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advocacy initiatives needed to be targeted toward governments, with a wide range of 431 
groups coming together to argue for change. Participants commented that ‘working 432 
together’ and ‘trying to work collaboratively’ was key to successful advocacy. Some 433 
participants considered that shifting to a public health approach for the prevention of 434 
gambling harm would enable the development of coalitions. This was because 435 
effective approaches to gambling reform would depend on getting ‘the philosophy 436 
right… a turnaround of the ideology… this is the only thing that will really make a 437 
difference’. Overall, participants argued for a clear shift in advocacy initiatives 438 
towards a focus on harmful products:  439 
 440 
“I think there’s an acceptance now that we need to look at population level 441 
effects and that we need to look at the product and move away from the 442 
individual responsibility.” - Participant 27, Academics/Researchers  443 
 444 
Engaging communities and those with a lived experience of harm  445 
 446 
Finally, were the challenges associated with engaging those with a lived experience 447 
of gambling harm, and local communities, in advocacy initiatives. Participants 448 
observed how the stigma associated with ‘problem gambling’ meant that potential 449 
advocates feared that such stereotypes might ‘jeopardise’ their jobs, relationships 450 
and result in negative judgments from others. This was a critical factor in ‘whether or 451 
not people decided to be involved’ in advocacy. Stigma extended beyond the 452 
individual, with family and friends also concerned about the negative impacts of 453 
people speaking out. Yet, participants acknowledged that encouraging individuals to 454 
speak out played a crucial role in achieving gambling reform. Participants 455 
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commented on the need to empower individuals with a lived experience of gambling 456 
harm to be involved in advocacy, arguing that those who had a lived experience of 457 
gambling harm, and their friends and families, were the most ‘authentic advocates 458 
for policy reform’. Participants suggested a range of initiatives that would encourage 459 
people with a lived experience of gambling harm to make a contribution to the 460 
debate about gambling reform. This included strategies such as advocacy and media 461 
training to enable the communication of the most up to date evidence about 462 
gambling related harm. As one participant stated: 463 
 464 
“There’s nothing more powerful than hearing a personal story from somebody 465 
who is actually just like you…” - Participant 18, Advocate 466 
 467 
Finally, some participants discussed the importance of ‘firsthand knowledge’, the 468 
need to build a ‘groundswell’ of support to advocate for gambling reform, and the 469 
power of grassroots movements in providing a voice for those who struggled to be 470 
heard:  471 
 472 
“…people who have less power and agency within society are always going to 473 
struggle to be heard. There’s the classic people who need the most advocacy 474 
always struggle to advocate for themselves because they don't have the 475 
social capital to do that and the knowledge and the networks.” - Participant 19, 476 






Although public health advocacy has previously been critical in reform on significant 481 
public health issues such as tobacco control (Chapman 2004a; Daube 2017), there 482 
has been limited discussion about how public health advocacy can address 483 
gambling-related harms (Thomas et al. 2015). The results of this study highlight that 484 
while no one clear advocacy strategy has been implemented across stakeholder 485 
groups, participants are actively engaging in advocacy associated with gambling 486 
harm reduction and prevention. However, this advocacy is fragmented in its 487 
implementation. The creation of a clear pathway or ‘road map’ is necessary to unite 488 
public health and other advocates and implement effective public health advocacy 489 
initiatives. This study provides the starting point for constructing this road map. 490 
 491 
A number of challenges, facilitators and effective strategies for advocacy responses 492 
in gambling harm reduction and prevention were identified in this study. Some of 493 
these challenges centred on the power of the gambling industry, which was 494 
perceived by participants as affecting all aspects of the advocacy process. These 495 
include potential conflicts of interest between organisations who would like to be 496 
involved in advocacy and their funding sources, donations to political groups, the 497 
distortion of evidence and influence over research priority setting. Similar issues 498 
have been identified in relation to other unhealthy commodity industries such as 499 
tobacco, junk food and alcohol (Brownell and Warner 2009; Freudenberg 2014; 500 
Brinsden and Lang 2015). The World Health Organization (WHO) (2003) has sought 501 
to address tobacco industry interference through mechanisms such as the WHO 502 
Framework Convention on Tobacco Control (FCTC), which commits all 181 503 
signatory governments to protect their tobacco control policies from the political 504 
influence of the tobacco industry (WHO 2003). Given the globalisation of gambling 505 
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products (Hellman et al. 2017), conventions such as the FCTC may also play a key 506 
role in reducing gambling harm. The FCTC focuses on the implementation of 507 
evidence-based strategies that can reduce the demand for tobacco products, the 508 
regulation of products, the supply of these products, education, and advertising 509 
restrictions. Research indicates that many of these strategies are used by the 510 
gambling industry to promote their products and to resist regulatory reform (Thomas 511 
et al. 2017). National and international conventions may support the development of 512 
clear strategies aimed at preventing and reducing gambling harm.  513 
 514 
A number of other advocacy challenges identified focused on practical limitations. 515 
Inadequate distribution of resources often limits advocates’ ability to implement 516 
effective strategies. Also apparent were the difficulties associated with different 517 
groups working together for a common goal. Coalitions are known to be important in 518 
bringing a variety of voices together and have been critical in the development of 519 
effective advocacy responses in other areas of public health (Douglas et al. 2015; 520 
Cullerton et al. 2016; Weishaar et al. 2016), such as the successful implementation 521 
of a range of tobacco free policies (Douglas et al. 2015; Weishaar et al. 2016). It was 522 
clear from participants’ responses that the development of gambling advocacy 523 
coalitions is critical in creating successful initiatives. However, those working to 524 
address gambling harm were often seen as appearing to focus on targeted, specific 525 
advocacy responses, rather than ‘big picture’ approaches. For example, advocacy 526 
initiatives were seen as often being reactive to single issues such as the regulation 527 
of gambling advertising in live sport, or specific behaviours associated with industry. 528 
Further, there is limited measurement of or reflection on the success of advocacy 529 
initiatives. At present there are few initiatives that take a long term, proactive focus 530 
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on bigger issues that would significantly prevent or reduce gambling related harm. In 531 
a previous paper we have argued that such big picture approaches would include 532 
embedding advocacy strategies into broader planning for public health initiatives, 533 
and developing coalitions with advocates working to reform other harmful industries 534 
(Thomas et al. 2015). Further steps should include development of a ‘road map’ to 535 
guide advocacy strategies, identify any commonalities with other public health issues 536 
(e.g. the advertising of products in sporting matches), and potential coalitions. As 537 
argued by participants in this study, this road map could be constructed within 538 
broader national or international public health strategies or international conventions. 539 
 540 
The engagement of those with a lived experience of gambling harm is important in 541 
highlighting issues by incorporating a human element with which people can identify 542 
(Jernigan and Wright 1996; Thomas et al. 2015). Given research that has highlighted 543 
the importance of the lived experience in successful advocacy initiatives (Holder and 544 
Treno 1997), the stigmatisation of individuals and their families who have 545 
experienced harm from gambling is an important issue to address. It is notable that 546 
engagement in advocacy for those with a lived experience of gambling harm will not 547 
necessarily involve talking to the media. Media advocacy is not for everyone, and 548 
people with a lived experience may wish to be involved in activities that do not 549 
involve recounting their experience. Organisations should therefore seek to provide a 550 
range of training and advocacy opportunities for those directly impacted by gambling 551 
harm, including individuals, their families, and communities. Some organisations 552 
have started to consider how to include people with a lived experience in advocacy. 553 
For example, the Champions for Change program in Australia (Alliance for Gambling 554 
Reform 2018) includes a range of participation options for people with a lived 555 
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experience of gambling harm, including engaging with the media, speaking to 556 
politicians and/or policy makers, engaging with the public and community groups, 557 
volunteering, and promoting venues that do not contain poker machines.  558 
 559 
Although current strategies to address gambling harm have predominantly focused 560 
on individual responsibility approaches, it is clear that there is a need to challenge 561 
this framing and present gambling harm as a broader public health issue. The use of 562 
individual responsibility rhetoric is a tactic known to be used by other unhealthy 563 
industries such as tobacco. Research has demonstrated that this framing deflects 564 
perceptions of harm away from products or industry practices and creates concern 565 
amongst the public regarding freedom of choice (Moodie et al. 2013; Friedman et al. 566 
2015). In addressing this, discussions about the causes of gambling harm need to 567 
continue to reiterate the society wide impact of gambling harm, while clearly linking 568 
this harm to a range of determinants, including gambling product and industries. 569 
 570 
Participants also spoke of some ideological challenges to effective advocacy. 571 
Advocacy is perceived as a strategic approach to advance social or public policy 572 
objectives, usually by organisations, whereas, personal activism can take more 573 
direct and less planned forms. Notwithstanding the overlaps in these definitions, and 574 
some confusion about the differences, what is important is the recognition that 575 
advocacy is essential in the creation of harm reduction and prevention strategies in 576 
gambling. Ensuring that advocacy is evidence based and that independent funding is 577 
available for research and services, and providing opportunities for academics to 578 
publish articles in journals which support researchers discussing the implications of 579 
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their research for policy and practice, may help to dispel some of the myths 580 
associated with engagement in advocacy. 581 
 582 
Consequently, this raises the question of how to create and develop feasible public 583 
health advocacy responses to address gambling harm. These responses are 584 
pictorially illustrated in Figure One. 585 
 586 
First, there is the need to develop and enable advocates, which could be done with a 587 
combination of different strategies. In the area of gambling, there is concern about 588 
the role of stigma in preventing individuals, particularly those with a lived experience 589 
of gambling harm, being involved in advocacy. It is therefore critical that those 590 
working in public health are mindful of the potential for stigma to occur when 591 
developing future advocacy campaigns and initiatives. Further, those mechanisms 592 
that enable community participation in advocacy by providing supportive 593 
environments (Flynn 2015) require consideration. For example, the creation of 594 
environments where healthy food choices were encouraged was critical in the 595 
effective implementation of sugar-sweetened beverage levies (soda taxes), where 596 
community driven advocacy was central to policy reform (Grumbach et al. 2017). 597 
 598 
There is a need to challenge the structural barriers created by industry influence. In 599 
public health there is a growing body of literature that argues that researchers should 600 
not accept funding from the industries they are studying (Stuckler and Nestle 2012; 601 
Chew et al. 2014). This would help ensure that researchers’ ability to advocate is 602 
uninhibited. Smith and Stewart (2017) suggest that by creating a collaborative 603 
environment, researchers could indirectly involve themselves in advocacy efforts 604 
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(Smith and Stewart 2017). Given the inherent conflict of interest created by industry 605 
being involved in research (Adams et al. 2010; Cowlishaw and Thomas 2018), it is 606 
clear that using alternative funding sources would be one way to address this 607 
conflict. 608 
 609 
Finally, there is a need to consider how best to use limited resources to create 610 
broadly based and consistent advocacy responses. Other industries (e.g. tobacco) 611 
have successfully promoted their products and prevented reform using consistent 612 
advocacy strategies (Menashe and Siegal 1998; Saloojee and Dagli 2000). A key 613 
component to the success of coalitions in other areas of public health has been the 614 
development of social capital (Dean and Gilbert 2009; Ogden et al. 2013). By 615 
building social capital among advocates for gambling reform - developing 616 
relationships with community members, government, academics, and researchers - it 617 
could be possible to create strong connections, and subsequently coalitions that can 618 
develop strategies, advocate for and ultimately implement gambling reform 619 
initiatives. It is important that strong, respected and informed public health leaders 620 
take a leading role in the coordination of coalitions.  621 
 622 
INSERT FIGURE ONE  623 
 624 
This study has a number of limitations. First, the initial recruitment of participants 625 
included recruitment and referral from those among the researcher’s networks, which 626 
contributed to the higher participation from individuals based in Australia. Second, 627 
although this study has a large sample size for a qualitative research study, it 628 
focuses on a specific group of individuals who were working predominantly in areas 629 
27 
 
of gambling reform. Thus, the study cannot be generalised to all individuals working 630 
in gambling research, policy, or practice. A larger sample of international 631 
participants, including those who work with or receive funding from industry, would 632 
provide a broader picture of attitudes across the gambling field. Given both the 633 
exploratory nature and specific focus of this study, more in-depth consultations with 634 
stakeholders should now be used to build a road map of specific public health 635 
advocacy strategies, which are relevant to different geographic or cultural contexts. 636 
Consensus among stakeholders could identify what feasible and realistic advocacy 637 
strategies for gambling harm should look like, including establishing (and 638 
implementing) evidence-based priority areas in relation to the reduction and 639 




There is a role for advocacy in future gambling harm reduction and prevention 644 
strategies. However, a number of key challenges need to be overcome for this to 645 
occur. Those working in public health could explore ways of addressing these 646 
challenges, learning from experience in advocacy on other public health issues, and 647 
consider how to create comprehensive and feasible strategies to facilitate public 648 
health advocacy in gambling with a continuing focus on clear and consistent 649 
messages, coalitions and community engagement. 650 
 651 
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Figure One  917 
Developing public health advocacy responses to reduce and prevent gambling 918 
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